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Abstract
Activation of naive CD8 T-cells can lead to the generation of multiple effector
and memory subsets. Multiple parameters associated with activation conditions are
involved in generating this diversity that is associated with heterogeneous molec-
ular contents of activated cells. Although naive cell polarisation upon antigenic
stimulation and the resulting asymmetric division are known to be a major source
of heterogeneity and cell fate regulation, the consequences of stochastic uneven par-
titioning of molecular content upon subsequent divisions remain unclear yet. Here
we aim at studying the impact of uneven partitioning on molecular-content hetero-
geneity and then on the immune response dynamics at the cellular level. To do so,
we introduce a multiscale mathematical model of the CD8 T-cell immune response
in the lymph node. In the model, cells are described as agents evolving and inter-
acting in a 2D environment while a set of differential equations, embedded in each
cell, models the regulation of intra and extracellular proteins involved in cell differ-
entiation. Based on the analysis of in silico data at the single cell level, we show
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that immune response dynamics can be explained by the molecular-content het-
erogeneity generated by uneven partitioning at cell division. In particular, uneven
partitioning acts as a regulator of cell differentiation and induces the emergence of
two coexisting sub-populations of cells exhibiting antagonistic fates. We show that
the degree of unevenness of molecular partitioning, along all cell divisions, affects
the outcome of the immune response and can promote the generation of memory
cells.
Keywords: Multiscale modeling, immune response, asymmetric division,
agent-based models, immune memory
1 Introduction
Following acute infection, the activation of naive CD8 T-cells by antigen presenting cells
(APCs) triggers the synthesis of proteins controlling cell proliferation and differentiation
up to the memory state. While CD8 T-cell population dynamics have been widely de-
scribed, it is of great interest to better understand the molecular mechanisms driving the
CD8 T-cell response. In particular, determining the effects of molecular events on the
generation of memory cells is necessary for vaccine design improvement. In vivo and in
vitro studies have demonstrated that a single presentation of the antigen to naive CD8
T-cells is sufficient to trigger a complete CD8 T-cell immune response [1, 2, 3, 4, 5]. Then,
once initiated, antigen-independent molecular pathways drive a program of CD8 T-cell
proliferation and differentiation [6, 7].
The CD8 T-cell immune response occurs through four main phases. First the activa-
tion of naive CD8 T-cells in secondary lymphoid organs such as lymph nodes (LN) or
spleen by APCs through MHC class I antigenic peptide/T-cell receptor (TCR) binding,
surface co-receptor/ligands interactions and soluble cytokines secretion. Once activated,
CD8 T-cells proliferate quickly during the expansion phase, which expands the initial pop-
ulation by a factor of 103 to 105 [6, 8]. Concomitantly, activated cells differentiate into
effector cells, able to kill infected cells through cytotoxicity. At the end of the expansion
phase, known as the peak of the response, the CD8 T-cell population begins a contrac-
tion phase, where most of the responding cells die yet leaving a quiescent population of
cells with strong re-activation potential: the memory cells. The memory cell population
survives the contraction phase and may remain for years in the organism (memory phase)
to ensure faster and stronger host-protection against subsequent infection by the same
pathogen.
The responding effector population is composite and two subsets with antagonistic
fates have been described [9]: memory precursor effector cells (MPEC) and short-lived
effector cells (SLEC), characterised by the expression of two proteins KLRG1 and CD127
(IL-7 receptor). Both MPEC (KLRG1loCD127hi) and SLEC (KLRG1hiCD127lo) express
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effector features (cytotoxicity, proliferation) but MPEC are capable of differentiation into
memory cells while SLEC are destined to die during the contraction phase [9]. Thus CD8
T-cell population dynamics arise from cell phenotypic heterogeneity, itself resulting from
molecular-content heterogeneity.
Among the genes, transcription factors and proteins involved in the CD8 T-cell re-
sponse, some seem to play key roles in the differentiation processes. Transcription factors
Tbet and Eomesodermin (Eomes) appear to play critical roles in the acquisition of ef-
fector and memory phenotypes. It has been shown that the expression of Tbet induces
the development of SLEC and represses the development of MPEC profiles [9, 10, 11].
Eomes is not involved in the SLEC versus MPEC fate choice [12, 13]. However, Eomes
is necessary for the development of several properties of memory cells (survival, lymph
node homing capacities, responsiveness to second infection [11, 12, 14]). Along the differ-
entiation from effector to memory, the concentration of Tbet in a CD8 T-cell decreases,
while the concentration of Eomes increases [11, 15].
Since a unique initial antigenic signal can trigger a complete response, additional mech-
anisms are necessary to generate the observed molecular-content heterogeneity. Chang et
al. [16, 17, 18, 19] showed that TCR binding to MHC-class-I peptide-complex results in
polarised segregation of proteins in activated CD8 T-cell: some proteins migrate on the
TCR side of the T-cell, other migrate on the opposite side. The subsequent division of the
activated CD8 T-cell splits the mother cell perpendicularly to the polarisation axis, such
that the daughter cell coming from the TCR side (proximal cell) receives more proteins
associated to effector lineage, including Tbet, while the other one (distal cell) receives
more proteins associated to memory lineage. Asymmetric division of polarised naive CD8
T-cells appears to be one of the major mechanisms regulating CD8 T-cell fate decision.
Nevertheless, the role of asymmetric division of polarised naive cells in the T-cell
differentiation process appears to be controversial [20]. While there are several evidences
for asymmetric division of polarised naive CD8 T-cells [21], it remains uncertain how
this polarisation quantitatively depends on the affinity of the TCR for the MHC-class-
I peptide-complex, the duration of the binding, external chemokines and interactions
with homotypic CD8 T-cells [21]. Since the asymmetric partitioning of Tbet has been
evidenced in mice CD8 T-cells, it will be considered hereafter.
Less is known about the partitioning of molecular content in the course of subsequent
cell divisions. However, several studies support the hypothesis that when a cell divides, a
random, uneven partitioning of the molecular content occurs [22, 23, 24, 25, 26, 27, 28, 29].
Partitioning of CFSE dye, a cell staining dye used to track cell proliferation through dye
dilution, during lymphocyte proliferation has been mathematically studied by Luzyanina
et al. [23, 26]. Based on comparison with in vitro experimental data, these studies suggest
that uneven partitioning, which does not result from cell polarisation, occurs at T-cell
division.
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We emphasize that the asymmetric first division of naive cells, which goes through
an active polarisation of the cell, has to be distinguished from the random partitioning
of the molecular content during the subsequent divisions of non-polarised cells, hereafter
referred to as uneven partitioning [29].
In a recent work (Girel and Crauste [30]), we studied how stochastic uneven molecular
partitioning, repeated at each cell division, could regulate the effector versus memory
cell-fate decision in a CD8 T-cell lineage. To do so, we analysed an impulsive differential
equation describing the concentration of the protein Tbet in a CD8 T-cell subject to
divisions, where impulses were associated with uneven partitioning of Tbet. In this work,
high and low Tbet concentrations were associated with effector and memory phenotypes,
respectively. We concluded that, for a low degree of unevenness of molecular partitioning,
a CD8 T-cell expressing a moderate concentration of Tbet can still generate both memory
and effector cells. If the concentration of Tbet in this cell is high or low enough, the
phenotype of the cell and its progeny becomes irreversible, with low Tbet-expresser and
high Tbet-expresser differentiating in memory or effector cells, respectively. Moreover,
our study indicates that the increase in cell cycle length throughout the immune response
[31, 32] favours irreversible cell differentiation.
Several works (see [33] and the references therein), focused on modeling molecular
mechanisms of the immune response coupled to cell population dynamics. Most of these
works involve agent-based models.
Gong et al. [34, 35] developed a two-compartment model to study how the number
of dentritic cells and the level of MHC-peptides on their membrane influence the size
and composition of T-cell populations. Since they did not model any dynamics at the
molecular level, they were limited in studying the molecular origins of cell differentiation
and heterogeneity.
Prokopiou et al. [36] and Gao et al. [37] designed a multi-scale agent-based model of
the early CD8 T-cell immune response (Day 3 to 5.5 post-infection). At the population
scale, a discrete population of CD8 T-cells and APCs in a LN is modeled by a cellular
Potts model (CPM) [38]. At the molecular scale, the dynamics of a simplified molecular
regulatory network (MRN) containing some key molecular factors is modeled by a system
of differential equations, embedded in each cell of the population, whose state determines
cell phenotype and fate. Cells communicate with each other through cell-cell contact
and secretion of the cytokine IL2 such that the environment of a cell affects its molecular
profile. Parameter calibration resulted in good agreement with in vivo data of an immune
response in murine LN after influenza infection, at both cellular and molecular levels.
The model presented in this article has been developed from the multi-scale agent-
based model previously introduced in [36, 37]. Since the authors in [36, 37] focused on
early events following CD8 T-cell activation, they did not consider processes leading to
the generation of memory cells. We enriched their model in order to study a complete re-
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sponse, from the activation of naive cells to the generation of memory cells. In particular,
Eomes has been added to the MRN.
In this paper, we are interested in understanding how, from the activation of naive CD8
T-cells, an antigen-independent regulation of intra-cellular molecular content can drive
a complete CD8 T-cell response. We particularly focus on the role of molecular-content
heterogeneity among a CD8 T-cell population in the generation of memory cells. We first
verify our model’s ability to reproduce in vivo data at both cellular and molecular scales.
Then we study, in an in silico CD8 T-cell population, the impact of molecular-content
heterogeneity on the emergence of sub-populations, characterised by their expression of
proteins Tbet and Eomes. We discuss how uneven distribution of molecular content at
cell division affects the cellular dynamics (population size, cell differentiation and death)
and suggest that memory cell generation efficiency is maximal for a moderate degree
of unevenness. Finally, we show that memory cells generated by our model are able
to reproduce some features of a secondary CD8 T-cell immune response. Indeed, when
restimulated by antigen in silico they generate more cells at the peak of the response and
in the memory phase.
2 Material, Methods and Model
2.1 Data
4×105 naive CD8 T-cells from CD45.1+ F5 TCR transgenic mice (B6.SJL-PtprcaPepcb/BoyCrl-
Tg(CD2-TcraF5, CD2-TcrbF5)1Kio/Jmar) recognizing the NP68 epitope were trans-
ferred intravenously in congenic CD45.2+ C57BL/6 mice (C57BL6/J). The day after
recipient mice were inoculated intranasally with 2 × 105 PFU (plaque forming units)
of a vaccinia virus expressing the NP68 epitope [39]. From day 4 to day 22 post-
infection, the spleens of infected animals where harvested and the number of F5 transgenic
CD8 responder T-cells was assessed by flow cytometry, based on CD8/CD45.1/CD45.2
expression, to distinguish F5 TCR-transgenic responder (CD45.1+CD45.2−) from host
(CD45.1−CD45.2+) CD8 T-cells. Naive (CD44− Mki67− Bcl2+), effector (CD44+ Bcl2-
) and memory (CD44+ Mki67− Bcl2+) CD8 T-cells have been identified [40]. All ex-
perimental procedures were approved by an animal experimentation ethics committee
(CECCAPP; Lyon, France), and accreditations have been obtained from the French gov-
ernment.
OT1 CD8 T cells mRNA expression data time courses come from the ImmGen project
(http://www.immgen.org). According to the information provided on ImmGen.org, the
in vivo mRNA data (Figure 4) were generated for OT1 T-cells stimulated in similar
experimental settings i.e. the response of transferred OT1 TCR-transgenic CD8 T-cells
following infection by vesicular stomatitis virus expressing their cognate antigen.
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Figure 1: Simplified molecular regulatory network in a CD8 T-cell. Red molecular fac-
tors dynamics are described by equations (1)-(6); yellow molecular factors dynamics are
described by equation (7); black arrows: promotion or secretion; green arrows: transition
between activated and non-activated form of IL2R; red dashed arrows: inhibition. The
meaning of the numbered arrows is reported in Table 1.
2.2 Molecular regulation and IL2 diffusion
We aim at describing the molecular regulation within each CD8 T-cell during a response
to an acute infection, and how the dynamical molecular state of a cell characterises its
differentiation stage. We present on Figure 1 the MRN that will be used throughout this
manuscript and give a detailed description in Table 1. It contains several key molecular
factors involved in CD8 T cell proliferation, differentiation, apoptosis, and cell commu-
nication. This is an updated version of the MRN developed in [36, 37] that was limited
to the description of differentiation up to the effector stage. To account for differentia-
tion into memory cells, we introduced the protein Eomes and its interactions with the
rest of the network as documented in the literature. Indeed, Eomes is involved in the
development of essential properties of memory cells such as survival, lymph node homing
capacities or faster response to antigenic stimulation [11, 12, 14].
2.2.1 Molecular regulatory network
This MRN is initiated upon antigen presentation to a naive CD8 T-cell, through the
engagement of the TCR. Antigenic stimulation triggers the synthesis of interleukine-2
(IL2) by the CD8 T-cell and the production of IL2 receptors (IL2R) on the cell membrane
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[41]. The synthesised IL2 is then released in the environment and can bind its receptor
[42] to form IL2-IL2R complex, hereafter referred to as activated IL2R. Activated IL2
receptors enhance the expression of IL2 receptors [41] as well as IL2 synthesis [41]. In
the meantime, activated IL2 receptors, jointly with protein Tbet (see below), inhibit the
activation of the IL2 gene through the action of the mediator protein Blimp1 [43, 44].
Antigenic stimulation independently stimulates Tbet synthesis [45], a protein involved
in the acquisition of cell cytotoxicity. Indeed, Tbet is known to induce the expression
of Fas ligand (FasL) [46], a transmembrane protein that can bind to the transmembrane
protein Fas to induce cell apoptosis via the activation of Caspases in the Fas-expressing
cell [47]. Caspases are a family of proteins playing essential role in cell apoptosis [48].
There exist several types of Caspases involved in CD8 T-cell apoptosis yet, for the sake
of simplicity, we aggregated them in a unique variable [Cas]. Moreover, Tbet induces its
own synthesis (via the gene Tbx21 ) [49, 50].
Eomes expression, involved in the acquisition of memory phenotype [12], is first in-
hibited during the activation phase due to engagement of the TCR (via activation of the
Akt/mTOR pathway and inhibition of FOXO1 and TCF7) [7, 13, 51]. Eomes is induced
later [11, 52] and its expression is enhanced by the activation of IL2 receptors [7, 13, 53].
Eomes promotes the development of new IL2 receptors on cell membrane [14].
The activation of IL2 receptors, of the TCR and the protein Eomes prevents apoptosis
by inhibiting the activation of Caspases, in particular through the mediator protein Bcl2
[12, 54, 55]
2.2.2 Intracellular molecular dynamics
Based on the above-described reactions, and from the equations used in [36, 37], we
describe the dynamics of the concentrations of non-activated IL2 receptors ([R]), activated
IL2 receptors ([L • R]), Tbet ([Tb]), activated Fas ([Fs∗]), Caspases ([Cas]) and Eomes
([E]) in a CD8 T-cell with the following system of equations
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n Description Re´f.
1 Activated TCR induces the development of IL2 receptors [42, 56]
2 Activated TCR induces the synthesis of Tbet [45]
3 Deactivation of activated IL2 receptors [42]
4 Activation of IL2 receptors [42]
5 Activated IL2 receptors induce the development of new IL2 receptors [41]
6 Activated IL2 receptors inhibit the expression of the IL2 gene (via Blimp1) [43]
7 Activated IL2 receptors induce the expression the IL2 gene [41]
8 Tbet enhances the inhibition of the IL2 gene by activated IL2 receptors [44]
9 Internal IL2 is secreted in extracellular environment [42]
10 External IL2 binds the non-activated IL2 receptors to activates them [41]
11 Tbet inhibits the secretion of IL2 [57, 58, 59]
12 TCR activation activates IL2 gene (via Erk) [41]
13 TCR activation inhibits the activation of Caspases (via Erk, Bim, Bax and Bcl2) [54]
14 Activated IL2 receptors inhibit the activation of Caspases (via Stat5, BAX et Bcl2) [55]
15 Tbet induces the expression of FasL [46]
16 FasL activates Fas through cell contact [47]
17 Activated Fas induces Caspases activation [47]
18 Tbet activates Tbx21 and induces the synthesis of Tbet (positive feedback loop) [49, 50]
19 Eomes induces the expression of IL2 receptors [14]
20 Activated IL2 receptors induce the expression of Eomes (via Runx3) [7, 13, 53]
21 Activated TCR inhibits Eomes gene expression (via Akt, mTOR, Tcf1, Foxo1) [7, 13, 51]
22 Eomes inhibits the activation of Caspases (via Bcl2) [12]
23 Tbet inhibits the expression of Eomes (via IFNγ, IL12R) [60, 61]
Table 1: Description of the molecular signalling pathways in Figure 1 and corresponding
bibliographic references.
d
dt
[R] =λR1fAPC + (µ
−
IL2 + λR2)[L •R] + λE1[E]−
(
µ+IL2[IL2
cm] + kR
)
[R], (1)
d
dt
[L •R] =µ+IL2[IL2
cm][R]− µ−IL2[L •R]− ke[L •R], (2)
d
dt
[Tb] =λT1fAPC + λT2
[Tb]n
λnT3 + [Tb]
n
− kT [Tb], (3)
d
dt
[Fs∗] =Hµ+F [Tb
cm]
(
λF
kF
− [Fs∗]
)
− µ−F [Fs
∗]− kF [Fs
∗], (4)
d
dt
[Cas] =Gλc1
1
1 + λc2[L •R]
·
1
1 + λc3fAPC
·
1
1 + λE2[E]
+ λc4[Fs
∗]− kc[Cas], (5)
d
dt
[E] =
1
1 + λE5fAPC
·
(
λE3[L •R]
λE6 + [L •R]
+
GλE4
1 + λE7[Tb]
)
− kE[E]. (6)
All parameters are positive. Parameters λ are associated to induction and inhibition
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effects, µ are associated to activation and deactivation of transmembrane proteins and k
are degradation and dilution rates. The concentrations of System (1)-(6) are assumed to
be null in naive CD8 T-cells, and remain null until TCR engagement.
The effects of the external environment on the intracellular system (1)-(6) are taken
into account through five variables. The variable fAPC (equations (1), (3), (5) and (6)) is
equal to the number of APCs bound to the considered CD8 T-cell and accounts for TCR
engagement. The variable G (equations (5) and (6)) is equal to 0 in nave CD8 T-cells
and to 1 otherwise, i.e. in cells that have already met with an APC. It accounts for the
fact that up-regulation of Caspases and Eomes described by parameters λc1 and λE4 is
not active in naive cells. The variable H (equation (4)) accounts for the expression of
FasL by effector and memory T-cells and for the activation of Fas through cell contact.
Hence, H is equal to 1 in a non-naive considered CD8 T-cell in contact with an effector
or a memory CD8 T-cell, and equal to 0 otherwise. The variable [IL2cm] is equal to
the concentration of IL2 at the cell membrane, in the extracellular environment. Finally,
[Tbcm] is defined as the sum of Tbet concentrations in effector and memory CD8 T-cells
in contact with the considered CD8 T-cell and acts as a proxy for the expression of Fas
in those cells.
We introduced the variable [E] and the associated equation (6) to the system used
in [37] in order to account for the synthesis of protein Eomes and its interactions with
other molecular factors. The term λE1[E] in (1) accounts for the up-regulation of IL2
receptors by Eomes. Eomes also limits cell apoptosis by activating Bcl-2 gene, as do
IL2 and activated TCR. This communal target explains the multiplicative form of the
inhibition of Caspases by Eomes, IL2 and TCR in equation (5). We also introduced the
function G in (5) to update the dynamics of Caspases concentration from [36, 37].
The positive feedback loop on Tbet is modeled with an order n Hill function in order
to allow bistable behaviour of Tbet. As discussed in the introduction, the concentration
of protein Tbet can be associated to the level of differentiation of an effector CD8 T-cell,
with high level of Tbet correlating with fully differentiated effector cell, while low Tbet
levels are associated to memory precursor effector cells. Proposition 1 below, reproduced
from [30], gives necessary and sufficient conditions to allow bistable behaviour of Tbet
concentration.
Proposition 1 ([30]). Assume fAPC = 0, n > 1 and λT2(n − 1)
n−1
n > nkTλT3, then
equation (3) has exactly three non-negative steady states: 0 < [Tb]u < [Tb]s, such that 0
and [Tb]s are locally asymptotically stable and [Tb]u is unstable.
In the following, we will assume that the conditions n > 1 and λT2(n−1)
n−1
n > nkTλT3
are fulfilled (see Section 3.2).
System (1)-(6) is embedded in every CD8 T-cell. Nevertheless, cell-cell contacts,
stochastic events (cell cycle length, protein distribution at division) and external concen-
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\ Property Division Apoptosis IL2 FAS FasL
Cell type \ secretion expression expression
APC ❍ ✔ ❍ ❍ ❍
Naive ❍ ❍ ❍ ❍ ❍
Pre-activated ❍ ✔ ✔ ❍ ❍
Activated ✔ ✔ ✔ ✔ ❍
Effector ✔ ✔ ✔ ✔ ✔
Memory ❍ ✔ ✔ ✔ ✔
Table 2: Main rules applying to APCs and CD8 T-cells in the model. ✔: able, ❍: unable
trations of IL2 affect the evolution of the system such that each CD8 T-cell develops a
unique molecular profile based on its own history.
2.2.3 Extracellular IL2 diffusion
The secretion of IL2 by CD8 T-cells and its isotropic diffusion in the extracellular domain
(with periodic boundary conditions) are modeled by the following PDE, introduced by
Prokopiou et al. [36],
∂[IL2]
∂t
= D∇2[IL2] +
(
λR3
[L •R]
λR4 + [L •R]
+ λ1fAPC
)
1
1 + λT4[Tb]
− δ[IL2], (7)
where [IL2] is the IL2 concentration. CD8 T-cells react to extracellular IL2 through their
IL2 receptors by means of the [IL2cm] term, in (1)-(2), defined as the sum of [IL2] at the
considered cell membrane.
2.3 Cell differentiation and division
Rules controlling cell division (including protein distribution at the division), apoptosis
and differentiation are summarised in Table 2 and detailed hereafter. It must be noted
that cells properties result from their molecular profile. For example, the properties
observed in vivo in memory cells (survival, low IL2 secretion, low cytotoxicity) are not
imposed by model rules but acquired as a consequence of their molecular profile. One
exception is cell cycle duration (see 2.3.2).
2.3.1 Differentiation
We designed a set of rules based on the linear, irreversible differentiation scheme from
[36, 37], allowing the description of a full CD8 T cell response, from the activation of naive
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Figure 2: CD8 T-cell differentiation scheme. Red arrows: proliferation; black arrows:
differentiation; th =threshold.
cells up to the generation of memory cells. The differentiation pathway is illustrated in
Figure 2.
A naive CD8 T-cell binding an APC becomes pre-activated and maintains the contact
with the APC thanks to good adhesion properties (cf. Section 2.4 and Table 3 from
Appendix Section A). If the concentration [L • R] of activated IL2 receptors in a pre-
activated CD8 T-cell reaches a given threshold IL2Rth, the pre-activated CD8 T-cell
becomes activated, leaves the APC, and starts to proliferate. When an activated CD8
T-cell divides, it gives birth to two CD8 T-cells whose states are determined by their
respective concentrations of protein Tbet by comparison with a given threshold Tbetth:
activated if [Tb] < Tbetth, effector otherwise. Finally, if the concentration of protein
Eomes is greater than the threshold Eomesth, a dividing activated or effector CD8 T-cell
will differentiate into memory cell and stop proliferating.
2.3.2 Cell cycle length
Division is considered only for activated and effector CD8 T-cells. The cell cycle length
(hours) of a cell preparing its k-th division (k ≥ 0) is chosen, at cell birth, from uniform
law U[ck−4,ck+4] where ck = 6 + 28k
2/(k2 + 100) such that the mean duration of the cycle
length increases with the number of divisions and can range from 2 to 32 hours [31, 32].
At the outcome of a division, activated and effector CD8 T-cells immediately enter a new
cycle.
2.3.3 Protein distribution between daughter cells
When a CD8 T-cell divides, the molecular content of the mother cell is randomly divided
between the two daughter cells. To account for protein distribution between daughter
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cells at each division and for each protein, let us introduce the parameter m, defined
as the degree of unevenness. We say that divisions are m% uneven if at division one
daughter cell inherits up to (50 +m/2)% of the mother cell’s content, while the second
daughter cell receives the rest, that is at least (50−m/2)% of the mother cell’s content.
Then, the molecular content of each daughter cell evolves according to System (1)-(6)
until the next division.
For the sake of clarity, we emphasise that the degree of unevenness m is not the
percentage of proteins received by daughters cells at each division but indicates to what
extent stochastic molecular partitioning can be uneven. Based on estimation from [26],
we consider that divisions are 10% uneven, so that the most uneven partitioning in this
case would split 45% and 55% of the mother cell’s proteins in the two daughter cells
respectively.
The exact value of each daughter cell molecular content at birth is randomly chosen
according to a probabilistic law, as detailed hereafter. Each protein concentration [i] of
the six proteins in System (1)-(6) is unevenly distributed among daughter cells: one cell
inherits ki[i] and the other (2− ki)[i]. Coefficients ki, i = 1, . . . , 6, are different for each
protein, each cell, and each division, and are chosen from the probability law U[1−m/100,1].
Unless otherwise indicated, we consider 10% uneven divisions [26], i.e. ki ∈ [0.9, 1] for
i = 1, . . . , 6. One may note that ki ∈ [0, 1] so the quantity of molecular material is
preserved at each division, given that the volume of each daughter cell is half the volume
of the mother. Different degrees of unevenness will be considered in Section 3.3.
One special case of division is the asymmetric division, and its associated unequal
repartition of Tbet between daughter cells. To account for polarisation of naive cells
by antigenic signalling and the consecutive asymmetric divisions, the first division of a
CD8 T-cell following its activation by an APC is characterised by a very specific uneven
distribution of protein Tbet only between the two daughter cells: a coefficient K is
randomly chosen from the uniform law U[0.5,1], one of the daughter cells is arbitrarily
designated as the proximal daughter and receives a concentration (2−K)[Tb] for protein
Tbet while the other one is designated as the distal one and receives a concentration
K[Tb] where [Tb] is the Tbet concentration in the mother cell, so that Tbet accumulates
in proximal cells [17, 18]. Other proteins concentrations are partitioned according to the
previously mentioned rule, see paragraphs above.
2.3.4 Apoptosis
CD8 T-cell apoptosis occurs as soon as Caspases concentration [Cas] reaches the threshold
Caspasesth. APCs are present from the beginning of the simulation and their lifetime
is randomly chosen from the uniform law U[48,96] (hours). APCs’ only role is to activate
naive CD8 T-cells, so we do not model any molecular activity within APCs. Dead cells
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are removed from the domain.
2.4 Spatial modeling and cellular interactions
At the cell population scale, we use a cellular Potts model (CPM), also known as Glazier-
Graner-Hegeweg model [38], to describe a population of CD8 T-cells and APCs evolving
in a two-dimensional domain. Basically, a CPM is a time-discrete algorithm where cells,
or agents, are defined as sets of nodes and move on a lattice, one node at a time, according
to probabilistic rules based on the minimisation of the energy of the system, known as
the Hamiltonian.
In our model, based on that from [36, 37], the domain is a square lattice of S =
150× 150 nodes with periodic boundary conditions. Each node ~x bears an index σ(~x). A
set of nodes bearing the same index σ defines a cell, also denoted by σ. Finally, each cell
σ has a type τ(σ) defining its properties. In our case, the different types are: extracellular
medium, APC, naive, pre-activated, activated, effector and memory CD8 T-cell. Note
that, technically, the extracellular medium is considered as a cell, denoted by σe.
Cell (including extracellular medium) size variation and displacement result from the
succession of copies of index from nodes to neighbour nodes, based on the minimisation of
the Hamiltonian Ω (see equation (8)), thanks to a simulated annealing algorithm. More
precisely, at each iteration, known as Monte Carlo Step (MCS), of the CPM, the following
algorithm is executed N = 3× S times:
Step 1 Randomly choose a source node xs and, among its first order neighbours, a
target node xg.
Step 2 Compute the Hamiltonian Ω, and the putative Hamiltonian Ω′ that would be
obtained if node xs would copy its index on node xg, i.e. if cell σ(xs) incorporates
the node xg.
Step 3 Compute ∆Ω = Ω − Ω′ + ∆motility (see equation (9) below) to evaluate the
energy cost of such a copy. If ∆Ω > 0, xs copies its index σ(xs) on xg, i.e. xg is
integrated by cell σ(xs). Else, the copy is accepted with probability exp(−∆Ω/T ),
known as Boltzman probability, where parameter T characterises the propensity of
the system to evolve.
Note that it is conventional to consider N = S pixel copy attempts per MCS. However,
in that case the maximum speed cells can reach is limited to approximatively 0.1 pixel
per MCS [62], which eventually defines a finer time resolution than expected for the
integration of differential equations. We emphasise that this limitation can be removed
by increasing this number (here N = 3× S).
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The Hamiltonian Ω is computed using the following formula:
Ω = λpm Σ
σ 6=σe
(pσ − Pτ(σ))
2
︸ ︷︷ ︸
perimeter
+ λarea Σ
σ 6=σe
(aσ −Aτ(σ))
2
︸ ︷︷ ︸
area
+ Σ
neighbours (~x, ~x∗)
Jτ(σ(~x)),τ(σ( ~x∗))(1− δσ(~x),σ( ~x∗))︸ ︷︷ ︸
contact
, (8)
where Jτ1,τ2 accounts for the contact energy between two cells of types τ1 and τ2. Thanks
to the term 1−δσ(~x),σ( ~x∗), two neighbour nodes belonging to the same cell do not generate
contact energy. pσ and aσ are the actual perimeter and area of cell σ, respectively,
whereas Pτ(σ) and Aτ(σ) are the target perimeter and area, respectively, for a cell of type
τ(σ) ; perimeter and area constraints then penalize the configurations where the effective
perimeter and area are distant from the target ones. Parameters λarea and λpm define
the weights of those two constraints. The perimeter constraint has been added to the
definition used in [36, 37] in order to avoid potential cell fragmentation.
The energy ∆motility is defined by
∆motility = v(σ(xs)) (cos(θ(σ(xs), t)), sin(θ(σ(xs), t))) · (xg − xs), (9)
where v(σ(xs)) is the weight associated to the motility energy for the cell σ(xs) and
θ(σ(xs), t) is the privileged angle of direction for the cell σ(xs) at time t, randomly
updated along the simulation. The operator “·” stands for the dot product. Thus,
∆motility is all the more high (and then the copy is all the more probably accepted) that
the copy direction (xg − xs) aligns with (cos(θ(t)), sin(θ(t))).
2.5 Numerical resolution
The initial cell population is composed of 30 naive CD8 T-cells and 3 APCs. A simulation
requires 30,000 iterations (MCS) corresponding to 20 days and 20 hours in the real time,
that is, 1 MCS represents 1 minute. When a simulation starts, APCs are already present
in the LN, ready to activate naive CD8 T-cells. We consider the initial time to be day 4
post-infection (D4 p.i.) since our in vivo data set starts D4 p.i..
We assume that a node of the lattice corresponds to 4 × 4µm2 for biological inter-
pretation. The target cell area is chosen to be 9 nodes (144µm2) for CD8 T-cells and
140 nodes (2240µm2) for APCs. The target perimeter for CD8 T-cells is 48µm in order
to favour compact shapes ; there is no constraint on APC perimeter. The simulations
have been performed using CC-IN2P3 servers on Compucell3D software [62] with, unless
otherwise stated, the parameter values from Tables 3, 4, 5 and 6 from Appendix Section
A.
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In Section 3.4, we study the ability of our model to simulate a secondary response,
also called memory response. Our model has first been calibrated in order to reproduce
an in vivo primary response against Listeria monocytogenes (Lm) infection from [63] (see
Figure 8). Then, the same parameter values have been used to simulated both a primary
and secondary responses. However, secondary response simulations are performed with
initially 3 APCs and 30 memory CD8 T-cells (instead of 30 naive CD8 T-cells for the
primary response) that are able to bind an APC to become pre-activated, then the differ-
entiation scheme presented in Section 2.3.1 applies. The molecular profile of the initial
memory cells is set as the asymptotic molecular profile developed by memory cells at the
end of a primary response, as discussed in Section 3.2.
2.6 Model calibration
Parameters of equations (1)-(9) have been calibrated on in vivo data using parameter
values from [36, 37]. Since handling big cell populations with an agent-based model
implies expensive computation time, we focused on fitting the proportion, rather than the
number, of CD8 T-cells in each state of differentiation among the whole cell population.
In order to compare in silico and in vivo data at both cellular and molecular scales we
minimised the metric D = Dcell +Dprot where
Dcell =
1
(#S)(#V )
∑
simulation S
·
∑
mouse V
·
∑
cellular type C
·
∑
time step t
|S(C, t)− V(C, t)| (10)
and
Dprot =
1
(#S)(#V )
∑
simulation S
·
∑
mouse V
·
∑
protein P
·
∑
time step t
|S(P, t)− V(P, t)|, (11)
with #S the number of simulations performed with a given set of parameters and #V
the number of mice from which in vivo data have been collected. S(C, t) (resp. V(C, t)) is
the ratio between the number of cells of type C and the size of the CD8 T-cell population
at time t in the simulation S (resp. the mouse V). S(P, t) (resp. V(P, t)) is the ratio
between the mean concentration of protein (resp. expression of mRNA) P among the
CD8 T-cell population at time t in the simulation S (resp. the mouse V) and the maximal
concentration (resp. expression) observed among all the time steps.
Since pre-activated and activated cellular types are not identified in in vivo data,
we gathered pre-activated with naive T-cells and activated with effector T-cells. Then
cellular types C in equation (10) are: naive/pre-activated, activated/effector and memory.
In equation (11), quantities P are the ones for which we have relevant in vivo mRNA
expression data at our disposal: IL2 receptors, Tbet and Eomes.
Note that we did not perform a parameter estimation procedure, but a calibration
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of our model based on experimental data. Evaluation of accuracy and sensitivity of
parameter values have been investigated in previous studies [37, 36]. Since we modified
the model to account for differentiation in memory cells, a sensitivity analysis of our
model to parameter Eomesth is presented in Appendix Section B.
3 Results
3.1 modeling the CD8 T-cell immune response at both cellular
and molecular scales
We first briefly illustrate our model’s ability to reproduce in vivo dynamics at both cellular
and molecular scales. The evolution of the composition of a CD8 T-cell population from
D4 to D22 p.i. is presented on Figure 3.A. In both in vivo and in silico data, naive CD8
T-cells are negligible after D6 p.i.. At the peak of the response, occurring D8 p.i. both in
vivo and in silico, more than 94% of the CD8 T-cells are in the activated or effector state,
while the memory population emerges during the subsequent contraction phase. As a
result of effector cell death and differentiation, memory cells represent the major part of
the population on D22 p.i.. Figure 3.B shows the size, in number of cells, of the CD8
T-cell population. The qualitative in vivo dynamics is quite well reproduced: antigen
presentation to naive CD8 T-cells triggers clonal expansion, population size reaches a
peak D8 p.i. followed by a contraction phase where most cells (64% and 67% in vivo and
in silico respectively) die.
On Figure 4, in silico predictions are compared to the mean IL2 receptors, Tbet
and Eomes mRNA expression levels of CD8 T cells activated in vivo. The kinetics of
IL2R and Tbet are well reproduced. Indeed, as a result of TCR engagement, IL2R
concentration sharply increases and reaches a peak D5 p.i., allowing cells to capture IL2
and get activated. Then IL2R concentration decreases until D8 p.i. and slowly increases
from D8 to D15 p.i.. Tbet concentration increases from D4 to D6 p.i. and remains
stable until D8 p.i., then decreases until D15 p.i.. Mean Tbet concentration consistently
correlates with the size of effector CD8 T-cell population (Figures 3.A and 4.B) and is
in agreement with its role in the control of cytotoxicity and cell apoptosis. Regarding
Eomes concentration, the in vivo increase between D4 and D8 p.i. is well reproduced by
our model, however the increase observed between D8 and D15 p.i. does not match the
in vivo data. As cells evolve towards a memory phenotype, in silico Eomes concentration
increases and up-regulates the expression of IL2R (Figure 1) to exacerbate the sensitivity
of memory cells to IL2. It should be noted that various works support that Eomes
expression increases in effector cells progressing toward a memory phenotype [11, 15, 45],
contrary to what is observed in the mRNA dataset from Immgen.
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Figure 3: CD8 T-cell population dynamics. (A) Fraction of each cell type among the
CD8 T-cell population. Grey: naive+pre-activated cells; red: activated+effector cells;
blue: memory cells; full lines with crosses: in silico (mean +/- standard deviation over
10 simulations); transparent lines with squares: in vivo (mean +/- standard deviation
over data from 5 mice). Error bars are most of time very small and then not visible. (B)
Size of the CD8 T-cell population in silico (black crosses, right y-axis, mean +/- standard
deviation over 10 simulations) and in vivo (blue squares, left y-axis, mean +/- standard
deviation over data from 5 mice).
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Figure 4: Molecular dynamics. Mean concentration of (A) both activated and inactivated
IL2 receptors, (B) Tbet and (C) Eomes among the CD8 T-cell population normalised
by the concentration value D8 p.i.. Lines with crosses: in silico (mean +/- standard
deviation over 10 simulations); squares: in vivo mRNA data from ImmGen.
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3.2 Cellular dynamics arise from cellular heterogeneity
In our model, each cell develops its own molecular profile, resulting in a heterogeneous
cell population. Consequently, studying the mean concentration of a given protein among
the population, as shown on Figure 4 for example, is not sufficient to understand the
molecular dynamics among the CD8 T-cell population.
To study the molecular-content heterogeneity and its role in cellular dynamics, we
show in Figure 5 the in silico concentrations of Tbet, Eomes and Caspases in each CD8
T-cell of the population at different times of the response. Cells were ranked according to
their Tbet content. D5 to D8 p.i., corresponding to the clonal expansion phase (see Figure
3), concentrations are heterogeneous but uniformly distributed around the mean value.
Most of that heterogeneity comes from the conditions of activation and from molecular
partitioning at cell division. Yet from D8 to D24 p.i., corresponding to the contraction
phase, two sub-populations of cells clearly emerge: one with high concentration of Tbet
(centred around [Tb]s ≈ 118 mol/L) and one with low concentration of Tbet (≈ 0 mol/L).
The unstable steady state of (3), defined in Proposition 1 and separating the stable
equilibria 0 and [Tb]s, is given by [Tb]u ≈ 21 mol/L. Moreover, cells expressing high
levels of Tbet express high levels of Caspases and low levels of Eomes, a molecular profile
associated with cell death and poor memory potential. On the contrary, cells expressing
low levels of Tbet have good survival and memory differentiation properties since they
express low levels of Caspases and high levels of Eomes. Progressively, cells with high
concentrations of Tbet die (when their concentrations of Caspases reach the threshold
Caspasesth ≈ 19 mol/L) and cells with low concentrations of Tbet differentiate into
memory cells and stop proliferating (when the concentration of Eomes reaches Eomesth =
16 mol/L). On D24 p.i. there is no cell with intermediary profile, most of the cells have
differentiated into memory cells while a few effector cells with high Tbet concentrations
still survive. One can observe that the molecular profiles of memory cells converge to the
same state where [Tb] = 0 mol/L, [E] ≈ 26 mol/L and [Cas] ≈ 9 mol/L.
The coexistence of two sub-populations characterised by their concentrations of Tbet
explains the population dynamics observed on Figure 3. That is, the contraction of the
cytotoxic effector cell population simultaneously with the emergence of a memory cell
population with survival properties.
As discussed in the introduction, responding CD8 T-cells can be distinguished between
short-lived (SLEC) and memory precursor (MPEC) effector cells based on the expression
of two proteins: KLRG1 and CD127 [7, 15]. In this section, we investigated how, in
our model, the heterogeneity of Tbet concentrations among a CD8 T-cell population
explains the emergence of two sub-populations of CD8 T-cells. The first one, expressing
high concentrations of Tbet, could be comparable to SLEC that exhibit properties such
as apoptosis and cytotoxicity, a process regulated by Tbet. The second one (memory
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Figure 5: Concentrations (mol/L) of Tbet (red), Eomes (blue) and Caspases (brown) in
all cells, sorted (left to right) according to their Tbet concentration. In silico CD8 T-cell
population on D5, D8, D13, D17, D21 and D24 post-infection are represented. To make
it easier to read, Eomes and Caspases concentrations have been multiplied by factor 5.
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potential, survival) would be similar to the MPEC population. This is consistent with
the litterature, since Tbet is known to favour the development of SLEC, to the detriment
of MPEC [9, 10, 11].
3.3 Moderate uneven molecular partitioning favours efficient
generation of memory cells
A major source of heterogeneity in our model is the uneven molecular partitioning at cell
division determined by the degree of unevenness m (see Section 2.3.3). We compare on
Figure 6 the sizes of the CD8 T-cell population at the peak of the response as well as the
sizes of the memory population on D25 p.i. for different degrees of unevenness, that is the
extent of unevenness of the stochastic molecular partitioning. We do not however modify
the degree of unevenness of the asymmetric first division, consecutive to the polarisation
of the cell due to APC binding [17, 18], see Section 2.3.3.
First, Figure 6 shows that the size of the CD8 T-cell population at the peak of
the response decreases as the degree of unevenness increases. Indeed, the more uneven
the molecular partitioning, the sooner CD8 T-cells expressing high levels of Caspases
or Eomes appear and then the sooner cells die by apoptosis or differentiate in non-
proliferating memory cells.
Second, the relation between the degree of unevenness and the size of the memory
population generated at the end of the response is not monotonous: the biggest memory
populations are observed when considering a moderate unevenness (10%-50%).
In Section 3.2, the role of Tbet concentration in determining the fate (death or memory
differentiation) of an effector CD8 T-cell has been discussed. Additionally, we showed in
[30] that the progression of a cell lineage towards death or memory differentiation can be
slowed down or reversed by molecular partitioning depending on cell cycle length, initial
Tbet concentration and the degree of unevenness. This stressed, on a simplified model,
the influence of the degree of unevenness on cell fate choice regulation.
On the opposite, when molecular partitioning is symmetrical (m = 0) and no fur-
ther T-cell-APC interactions are assumed, there is no more source of stochasticity and
consequently all the CD8 T-cells of the same lineage express the same concentration of
Tbet. As a consequence of Proposition 1, this concentration irreversibly converges ei-
ther to [Tb]s (high Tbet concentration) or to 0 mol/L (low Tbet concentration). This
irreversibly leads to apoptosis (high Tbet concentration) or memory differentiation (low
Tbet concentration) of the whole cell lineage.
Thus, our result clearly stresses that uneven partitioning allows the maintenance
of a CD8 T-cell compartment with undetermined fate for some time, through cell fate
reversibility. As long as it is maintained, this compartment is able to produce both
effector cells destined to die and memory cells.
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Figure 6: Size of the CD8 T-cell population at the peak of the response (black squares,
left axis) and size of the memory CD8 T-cell population at the end of the response D25 p.i.
(blue diamonds, left axis) as functions of the degree unevenness of molecular partitioning
(mean +/- standard deviation over 5 simulations). Red crosses (right axis) show memory
cell generation efficiency, measured as the ratio between the size of the memory CD8
T-cell population D25 p.i. and the size of the CD8 T-cell population at the peak of the
response (mean over 5 simulations).
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We also showed in [30] that the higher the degree of unevenness, the more reversible
the cellular fate. Surprisingly, strong unevenness (65%− 80%) results in smaller memory
cell populations (Figure 6). In fact, strong unevenness favours the fast emergence of
daughter cells with very high or low concentrations of Tbet such that those cell lineages
are likely to die or to generate memory cells. In particular, effector cells with high memory
potential poorly expand before they differentiate hence this leads to the generation of
fewer memory cells.
To discuss the efficiency of memory cell generation, we compare on Figure 6 the
number of memory cells generated at the end of the response to the number of cells at
the peak of the response, viewed as an indicator of the energetic cost of the response for
the organism (red crosses). Figure 6 suggests that the degree of unevenness in molecular
partitioning impacts memory generation, with the better ratio (more than 30%) obtained
when considering 50% uneven molecular partitioning.
3.4 Memory response
One of the characteristics of memory cells is their capacity to mount more rapid effector
response than naive cells and to generate an increased fraction of memory cells [64]. To
test whether the memory cells generated by our model exhibit some of these features we
compared the in silico primary response with a secondary response of in silico generated
memory cells.
Figure 7 shows the in silico memory response (or secondary response), obtained with
an initial population of 30 memory T-cells, as described in Section 2.5. This secondary
response is compared to the primary immune response starting with 30 naive CD8 T-cells
(Section 3.1). The in silico secondary response is characterised by a bigger CD8 T-cell
population, at any time of the response. From the primary to the secondary response,
there is a small increase in the size of the sub-population of activated and effector cells but
the major change is in the size of the memory population. Indeed, the number of memory
CD8 T-cells increases much faster during the secondary response such that D29 p.i. the
memory population is two times bigger than during the primary response. This can
be explained by the fact that memory cells are activated faster than naive cells, thanks
to their molecular profile. Indeed, memory cells express higher concentrations of IL2
receptors than naive cells, since it is sustained by the expression of Eomes. Consequently,
the threshold IL2Rth (see Section 2.3.1) is reached sooner when starting with memory
cells than with naive cells. As a result, the concentration of Tbet, up-regulated during
APC binding, is lower after the activation of a memory cell than after the activation of a
naive cell, and low Tbet level is associated to memory precursor fate and low cytotoxicity.
On Figure 8, we compare in silico primary and secondary responses from our model
with in vivo primary and secondary responses against Lm infection from [63]. Since our
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Figure 7: Number of (A) activated/effector and (B) memory CD8 T-cells during in silico
primary (dashed line) and secondary (full line) responses. Mean +/- standard deviation
over 10 simulations.
model has been calibrated to fit the primary response data, we do not aspire to reproduce
the quantitative dynamics of the secondary response, but rather to study its qualitative
properties. Namely, the secondary response is characterised by a slower and weaker
contraction phase, from the peak of the response D7 p.i. to the last time point D29 p.i..
This weaker contraction could be explained by an early production of memory cells that
leads to a large population of memory cells, as it is the case in our model (Figure 7).
4 Discussion
Activation of naive CD8 T-cells triggers a primary immune response, characterised by
a well orchestrated program of cell proliferation, differentiation, death and migration.
It is now well known that the responding CD8 T-cell population is heterogeneous and
that a single naive T-cell can generate differently fated cells [65]. However, evaluating
how cellular and molecular events contribute to that heterogeneity and identifying its
consequences on the outcomes of the immune response remain fundamental questions.
With this in mind, we expanded a hybrid multi-scale model of the CD8 T-cell immune
response, where cell behaviour is determined by intracellular molecular dynamics. Model
parameters have been calibrated using in vivo data at both cellular and molecular scales.
Because of expensive running time, we were led to simulate small cell populations so that
we focused on semi-quantitative fitting criteria. After calibration, our model succeeded
in reproducing the temporal dynamics of the response regarding the size of the CD8 T-
cell population and the proportion of cells in each differentiation stage. Apart from a
discordance between in silico and in vivo mean concentration of Eomes on day 15 p.i.,
our model captured the dynamics of the mean concentration of IL2 receptors, Tbet and
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Figure 8: Number of CD8 T-cells, normalised by CD8 T-cell population size D7 p.i.,
during in silico primary (black full line) and secondary (blue dashed line) responses
(mean over 10 simulations) compared with in vivo primary (black squares) and secondary
(blue triangles) responses against Listeria monocytogenes from [63].
Eomes, which play key roles in the differentiation processes.
In addition to reproduce primary responses, our model easily produces secondary
responses. Memory cells generated during the in silico primary response succeeded in
mounting a stronger secondary response upon antigenic stimulation (Figure 7 and Figure
8). It should be noted that the differences between outcomes of the primary and secondary
in silico immune responses only depend, in this work, on the difference between the
molecular profile of memory and naive CD8 T-cells and do not take into account a lot
of characteristics of the secondary response described in the literature such as: biggest
initial CD8 T-cell population [8], shorter cell cycle [66] or sensitivity to inflammatory
cytokines, such as IL12 [15].
We discussed how a deterministic description of molecular concentration dynamics
combined with stochastic events, such as uneven partitioning of molecular content at
division, can regulate the emergence and the maintenance of two sub-populations of
CD8 T-cells. Those sub-populations, characterised by their molecular profiles, coexist
but express different properties and antagonistic fates, comparable to those of SLEC
and MPEC described in the literature [9]. From that observation, we showed that the
dynamics observed at the cellular scale (cell differentiation, population size) could be
explained by molecular-content heterogeneity among the cell population, which mostly
originates from uneven partitioning of molecular content. We did not however consider
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the effect of stochastic fluctuations of gene expression, known to be an important source of
heterogeneity [67]. Interestingly, Huh and Paulsson [25] showed that both stochastic gene
expression and stochastic partitioning of molecular content are equally good to explain
the heterogeneity observed at cell division and suggested that much of the heterogeneity
usually attributed to the former actually results from the latter.
In our model, cell phenotypic heterogeneity, associated with molecular-content hetero-
geneity, first arises upon asymmetric division of polarised naive cells. This heterogeneity
is thereafter continuously regulated throughout the whole response by means of uneven
partitioning of molecular-content at each division. This is in agreement with the observa-
tions of Lemaˆıtre et al. [68] who state that T-cell diversification is a continuous process,
spread over the whole response, including the asymmetric first division and late events
occurring throughout subsequent divisions. Besides, Lemaˆıtre et al. [68] pointed out that
cellular heterogeneity, that could result from variations in naive T-cell responsiveness to
cytokines or TCR signalling, pre-exists prior to the first division. In this article we did not
consider preexisting heterogeneity among the naive T-cell pool, that could be achieved
by varying the parameter values of System (1)-(6) associated to each naive T-cell. We
can expect that it would confer to each naive T-cell a predisposition to engender a cell
lineage oriented toward either apoptosis or memory differentiation. Moreover, the initial
heterogeneity among naive T-cells could be conserved through the response, then leading
to a heterogeneous pool of memory cells, a feature that is not reproduced by our model
[69].
Polarisation of naive cells upon antigenic stimulation has been observed in CD4 T-
cells [21, 70] and B-cells [21, 71, 72]. This polarisation results in asymmetric division of
naive cells and may induce heterogeneous cell fates [70, 71, 72]. Regarding the subsequent
divisions, it can be thought that they are subject to uneven and random partitioning of
molecular content since this phenomenon has been reported in many types of cells, in-
cluding yeast, bacteria and T-cells [22, 23, 24, 25, 26, 27]. However, the contribution of
uneven and random partitioning of non-polarised cells in the development of heteroge-
neous cell fate has not been studied yet. To that end, it would be interesting to extend
the approach developed in our study to the differentiation of other lymphocytes, such as
B-cells or CD4 T-cells.
In our study, increasing the degree of unevenness of molecular partitioning reduces the
expansion size of the whole CD8 T-cell population whereas the size of the sub-population
of memory cells is maximal for intermediate degrees of unevenness. As a consequence, the
ratio between the number of memory cells generated and the magnitude of the response
at its peak, viewed as a measure of memory generation efficiency, is maximised when
considering a 50% degree of unevenness. As discussed above, molecular partitioning is
not the only regulator of heterogeneity. In this regard, we can believe that our evaluation
overestimates the value of this optimal degree of unevenness and rather indicates that
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generating a moderate heterogeneity all along the immune response leads to efficient
memory generation.
In our manuscript, when the degree of unevenness is m = 10%, each daughter cell
inherit from 45 to 55% of the mother cell’s molecular content, with uniform probability
distribution. The unevenness of molecular partitioning remains difficult to measure ex-
perimentally. Based on in vitro experimental data of CFSE dye expression, Luzyanina et
al. [26] estimated that the two daughter cells inherit of 42,3% and 57,7% of the mother
cell’s molecular content, respectively. Rather than considering a uniform probability dis-
tribution and a degree of unevenness, we could consider that the molecular partitioning is
a binomial phenomenon [24], i.e. each protein has the same probability to be attributed
to each daughter cell. Such a discrete distribution can be approximate by a continu-
ous and truncated (to avoid negative values) normal distribution whose variance would
characterise the level of unevenness.
Note that, in works dealing with the CD8 T-cell immune response, it is usual to con-
sider that 5 to 10% of the cells present at the peak of the response survive the contraction
phase and differentiate into memory cells [8]. This is consistent with our results only for
symmetric divisions or for divisions with high (65% to 80%) degrees of unevenness. How-
ever, this hypothesis can be challenged, as pointed out in [40], as for the actual in vivo
data presented in Figure 3, D22 p.i. the memory population size is 19.5% of the whole
population at the peak of the response, D8 p.i.. This suggests that the amplitude, and
possibly the kinetics, of the cellular contraction is not only an inherent feature of the CD8
immune response but also depends on external factors such as inflammatory factors.
In many mathematical models of the CD8 T-cell immune response, as those refer-
enced in [6], cell proliferation and differentiation depend on the amount of pathogen, in
the manner of prey-predator models used in ecology. In our model a brief initial antigenic
stimulation of naive CD8 T-cells is sufficient to trigger an autonomous program of prolifer-
ation and differentiation, as stated in the literature [1, 2, 3]. However, while dispensable,
in vivo inflammatory signals can affect the immune response outcome [73]. A motivating
perspective is to evaluate the respective contributions of both the autonomous program
and extrinsic inflammatory factors to the immune response, so that the latter could be
tuned by mastering the inflammatory environment. For example, extending our model by
incorporating the inflammatory cytokine IL12, secreted by APCs, could markedly affect
the effector/memory cell balance since IL12 is known to respectively promote and repress
Tbet and Eomes synthesis [9, 57, 74].
Cell cycle length depends in our model on the number of divisions the cell has un-
dergone. It would be instructive to introduce a molecular control of cell proliferation,
since the putative existence of coexisting sub-populations with disparate cycle lengths
could considerably impact the cellular dynamics. One could for instance consider the
transcription factor Foxo1, known to induce Eomes expression while repressing that of
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Tbet and inhibiting cell cycle progression [75], suggesting that the TbetloEomeshi mem-
ory precursor cells discussed in Section 3.2 might adopt a longer cycle than the Tbethi
Eomeslo cells.
In conclusion, our agent-based multiscale model successfully reproduced several as-
pects of the CD8 T-cell immune response at both molecular and cellular scales. Even
though we cannot infer quantitative conclusions from this study, it suggests that uneven
partitioning of molecular content at cell division, as a source of heterogeneity, can mod-
ulate cell fate decision and act as a regulator of the magnitude of the response and of
the size of the memory cell pool. Actually, we did not consider intermediaries, namely
DNA transcription and mRNA translation, between gene activation and protein synthe-
sis. Consequently, our molecular model is an amalgam between gene activity and protein
synthesis. Therefore, while our argumentation is based on uneven partitioning of the
molecular content, it could also stand for the situation where, when a cell divides, the
two daughter cells inherit different gene activity levels for each gene. All in all, our study
focus on molecular heterogeneity generation upon cell division in general, rather than the
specific case of molecular partitioning. It stresses that dynamics observed at the cellular
scale — including the initiation of the contraction phase and the origin of memory cells
— can be explained by structural molecular-content heterogeneity, that is continuously
regulated along the response, as CD8 T-cells divide.
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A Parameter values
Parameter Description Value Reference
AT target area of CD8 T-cell 144 µm
2 [37]
AAPC target area of APC 2250 µm
2 calibration
PT target perimeter of CD8 T-cell 48 µm calibration
λpm weight of perimeter constraint 10 calibration
λarea weight of area constraint 10 [36]
T temperature 10 [36]
JAPC,m APC-medium contact energy 30 [36]
JT,m CD8 T-cell-medium contact energy 30 [36]
JAPC,APC APC-APC contact energy 100 [36]
JAPC,NPA APC-naive or preactivated CD8 T-cell 35 [36]
contact energy
JAPC,AEM APC-activated, effector or memory 100 calibration
CD8 T-cell contact energy
JT,T CD8 T-cell-CD8 T-cell contact energy 100 [36]
v(σAPC) weight of motility energy for an APC 25 [37]
v(σPA) weight of motility energy for a 0 [37]
preactivated CD8 T-cell
v(σT ) weight of motility energy for a 250 [37]
CD8 T-cell (except preactivated)
Table 3: Estimated parameter values for the Cellular Potts model. Weights, temperature
and energies are dimensionless parameters.
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Parameter Value Unit Reference
Strengths of feedbacks
λR1 0.58 mol L
−1 min−1 calibration
λR2 0.007 min
−1 calibration
λE1 0.001 min
−1 calibration
λT1 0.07 mol L
−1 min−1 calibration
λT2 0.06175 mol L
−1 min−1 calibration
λT3 35 mol L
−1 calibration
λc1 0.096 mol L
−1 min−1 calibration
λc2 0.07 L mol
−1 calibration
λc3 0.23 / calibration
λc4 1.4 min
−1 calibration
λE2 0.073 L mol
−1 calibration
λE3 0.06 mol L
−1 min−1 calibration
λE4 0.09 mol L
−1 min−1 calibration
λE5 20 / calibration
λE6 10 mol L
−1 calibration
λE7 0.035 L mol
−1 calibration
Degradation rates
kR 0.0077 min
−1 calibration
ke 0.0154 min
−1 calibration
kT 0.00051 min
−1 calibration
kF 0.003 min
−1 calibration
kc 0.0038 min
−1 [36]
kE 0.0035 min
−1 calibration
Association/dissociation rates calibration
µ+IL2 6× 10
6 L mol−1 min−1 calibration
µ−IL2 0.12 min
−1 calibration
µ+F 0.0002 L mol
−1 min−1 [37]
µ−F 0.004 min
−1 [36]
kE 0.0035 min
−1 calibration
Other
λF 4.2×10
−5 mol L−1 min−1 [36]
n 3 / calibration
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Table 4: Parameter values for System (1)-(6).
Parameter Value Unit Reference
λR3 5×10
−9 mol L−1 min−1 calibration
λR4 15 mol L
−1 calibration
λT4 0.08 L mol
−1 calibration
λ1 3× 10
−8 L mol−1 calibration
D 1.776 µm2 min−1 calibration
δ 0.187 min−1 [37]
Table 5: Parameters values for equation (7).
Thresholds Value Unit
IL2Rth 62.9 mol L
−1
Tbetth 16.8 mol L
−1
Eomesth 16 (15.6 in Section 3.4) mol L
−1
Caspasesth 19.42 mol L
−1
Table 6: Threshold values for differentiation and death of CD8 T-cells.
B Sensitivity analysis to parameter Eomesth
In this paper, we enriched previous models [37, 36] in order to allow differentiation into
memory cell. In our model, this differentiation occurs when the concentration of protein
Eomes in an activated or effector cell crosses the threshold Eomesth (see Section 2.3.1).
Here, we discuss how sensitive our model is to this parameter. Sensitivity to other
parameters has been investigated in [37] and [36].
It is no surprise that the number of memory cells at the end of the response (D25
p.i) is highly sensitive to Eomesth value, as shown on Figure 9.A. Indeed, for low values
of Eomesth, the memory precursor cells identified in Section 3.3 differentiate early while
for higher values of Eomesth they can accomplish a few additional rounds of division
before their Eomes concentrations are sufficiently high to trigger memory differentiation,
leading to bigger memory cell populations. Indeed, Figure 9.B illustrates that the lower
the value of Eomesth, the sooner the pool of memory CD8 T-cells stops to expand.
We can see on Figure 9.C that the number of cells at the peak of the response (i.e. the
maximal expansion size reached by the CD8 T-cell population) is less sensitive to the value
Eomesth. However, it appears that the peak population size slightly increases with the
value of Eomesth. This is mainly due to the reason exposed above, i.e. memory precursor
effector cells proliferate more before their differentiation into non-dividing memory cells.
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It is also worth noting that if Eomesth is too low, CD8 T-cells can differentiate into
memory cells even if their molecular content does not match with the expected properties
of memory cells (survival and low cytotoxicity). Indeed, if Eomesth is 90% (resp. 95%)
of its base value (see Table 6), an average of 3.6 (resp. 0.4) memory cells die during the
response (mean over 5 simulations, results not shown) while for the base value of Eomesth
or upper values there is no memory cell death.
Figure 10 represents the mean concentration of IL2 receptors, Tbet and Eomes among
the CD8 T-cell population from D4 to D15p.i., for different values of Eomesth. Since
Eomes expression is associated with memory phenotype, it is no surprise that Eomes
concentration increases more slowly, or even decreases, for low values of Eomesth. On
the opposite, high values of Eomesth, associated with big memory cell populations, lead
to decreasing Tbet concentrations.
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Figure 9: Sensitivity analysis to parameter Eomesth. (A) Number of memory cells at the
end of the response D25 p.i., (B) day at which the last differentiation into memory cell
occurs and (C) number of CD8 T-cells at the peak of the response as functions of the
parameter Eomesth (mean +/- standard deviation over 5 simulations). Results are shown
for variations of −10%, −5%, +2.5%, +5% and +10% from the base value of Eomesth
(Table 6).
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Figure 10: Mean concentration of (A) IL2 receptors, (B) Tbet and (C) Eomes among the
CD8 T-cell population normalised by the concentration value D8 p.i. for different values
of Eomesth (mean over 5 simulations). Results are shown for variations of −10% (red
stars), −5% (orange crosses), 0% (yellow discs), +5% (light blue triangles) and +10%
(dark blue squares) from the base value of Eomesth (Table 6).
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